tiprankstipranks
ACADIA Pharmaceuticals (MX:ACAD)
:ACAD
Mexico Market
ACAD
ACADIA Pharmaceuticals
RESEARCH TOOLSreports

ACADIA Pharmaceuticals (ACAD) Stock News & Sentiment

0 Followers
Acadia Pharmaceuticals Reaches Preliminary Derivative Lawsuit Settlement
Premium
Company Announcements
Acadia Pharmaceuticals Reaches Preliminary Derivative Lawsuit Settlement
3d ago
8K
ACAD
ACADIA: EU Orphan Drug Launch Underscores Pricing Strength; Buy Rating and $37 Price Target Reaffirmed
Premium
Ratings
ACADIA: EU Orphan Drug Launch Underscores Pricing Strength; Buy Rating and $37 Price Target Reaffirmed
21d ago
ACAD
ACADIA: Buy Rating Reiterated as Daybue Momentum Builds and Key Pipeline Catalyst Nears; Price Target Maintained at $36
Premium
Ratings
ACADIA: Buy Rating Reiterated as Daybue Momentum Builds and Key Pipeline Catalyst Nears; Price Target Maintained at $36
21d ago
ACAD
Analyst Lifts ACADIA Price Target to $40 on Favorable Risk‑Reward and RADIANT Alzheimer’s Psychosis Upside
Premium
Ratings
Analyst Lifts ACADIA Price Target to $40 on Favorable Risk‑Reward and RADIANT Alzheimer’s Psychosis Upside
21d ago
ACAD
Costco’s Healthcare Move Turns Heads. We’re Buying These Pharma Stocks Instead.
Premium
Market News
Costco’s Healthcare Move Turns Heads. We’re Buying These Pharma Stocks Instead.
27d ago
JNJ
MRK
ACADIA Pharmaceuticals: Buy Rating Reiterated on Undervalued Growth Story; $36 Price Target Unchanged
Premium
Ratings
ACADIA Pharmaceuticals: Buy Rating Reiterated on Undervalued Growth Story; $36 Price Target Unchanged
1M ago
ACAD
ACADIA Pharmaceuticals Earnings Call Signals Growth Momentum
Premium
Company Announcements
ACADIA Pharmaceuticals Earnings Call Signals Growth Momentum
1M ago
ACAD
More MX:ACAD News >

ACAD News on the Web

Acadia Pharmaceuticals price target raised to $28 from $27 at Morgan Stanley
TipRanks News
Bullish
Neurocrine's Ingrezza Sales Keep Growing: Can the Momentum Last?
Zacks
Neutral
Costco’s Healthcare Move Turns Heads. We’re Buying These Pharma Stocks Instead.
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and ACADIA Pharmaceuticals (ACAD)
TipRanks News
Bullish
Acadia Pharmaceuticals (ACAD) Q2 2026 Earnings Call Transcript
The Motley Fool
Neutral
ACADIA Pharmaceuticals Earnings Call Signals Growth Momentum
TipRanks News
Bullish
ACADIA Pharmaceuticals: Strong Daybue Outperformance, STIX Uptake, and Raised FY26 Revenue Outlook Support Buy Rating
TipRanks News
Bullish
Mizuho Securities Sticks to Their Buy Rating for ACADIA Pharmaceuticals (ACAD)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
MX:ACAD
Sector Average
Media Buzz
This Week1 articles
Weekly Average5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MX:ACAD’s Media Buzz Sentiment?
1 articles about MX:ACAD were published this week. In an average week, 5 articles are published.
    What is MX:ACAD’s weekly average amount of articles?
    In an average week, 5 articles about MX:ACAD are published.
      What is MX:ACAD’s News Sentiment?
      100% of articles about MX:ACAD were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        BAYRYBayer
        MRKMerck & Company
        TMDXTransMedics Group
        FSPKFFisher & Paykel Healthcare Corporation Limited
        KURAKura Oncology
        Showing the stocks with the most bullish news sentiment over the past week